[1]
Ali, I. et al. 2019. RESPONSE RATE OF SOFOSBUVIR BASED ANTIVIRAL THERAPY AMONG PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 3A. Journal of Medical Sciences. 27, 4 (Dec. 2019), 295–301.